Stockreport

Blueprint's Avapritinib Shows Promise For Indolent Systemic Mastocytosis [Seeking Alpha]

Blueprint Medicines Corporation  (BPMC) 
Last blueprint medicines corporation earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: blueprintmedicines.com
PDF SummaryBlueprint's avapritinib may have another blockbuster indication in the making: indolent systemic mastocytosis.Avapritinib efficacy and safety profile in this popu [Read more]